Investigation of D₂ receptor-agonist interactions using a combination of pharmacophore and receptor homology modeling

ChemMedChem
Marcus MaloPeder Svensson

Abstract

A combined modeling approach was used to identify structural factors that underlie the structure-activity relationships (SARs) of full dopamine D₂ receptor agonists and structurally similar inactive compounds. A 3D structural model of the dopamine D₂ receptor was constructed, with the agonist (-)-(R)-2-OH-NPA present in the binding site during the modeling procedure. The 3D model was evaluated and compared with our previously published D₂ agonist pharmacophore model. The comparison revealed an inconsistency between the projected hydrogen bonding feature (Ser-TM5) in the pharmacophore model and the TM5 region in the structure model. A new refined pharmacophore model was developed, guided by the shape of the binding site in the receptor model and with less emphasis on TM5 interactions. The combination of receptor and pharmacophore modeling also identified the importance of His393⁶·⁵⁵ for agonist binding. This convergent 3D pharmacophore and protein structure modeling strategy is considered to be general and can be highly useful in less well-characterized systems to explore ligand-receptor interactions. The strategy has the potential to identify weaknesses in the individual models and thereby provides an opportunity to improve the...Continue Reading

References

Oct 1, 1992·European Journal of Pharmacology·A MansourH Akil
Jul 1, 1987·Journal of Computer-aided Molecular Design·R TonaniG R Marshall
Jul 1, 1987·Journal of Computer-aided Molecular Design·I Pettersson, T Liljefors
Jan 1, 1994·Pharmacology & Therapeutics·D M Jackson, A Westlind-Danielsson
Feb 1, 1994·Journal of Computer-aided Molecular Design·G Lauri, P A Bartlett
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·K WielandM J Lohse
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Feb 1, 2000·The Journal of Biological Chemistry·P GhanouniBrian K Kobilka
Aug 5, 2000·Science·K PalczewskiM Miyano
Oct 3, 2002·Journal of Neurochemistry·Sarah L PaynePhilip G Strange
Jan 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Lei Shi, Jonathan A Javitch
Nov 4, 2004·Journal of Receptor and Signal Transduction Research·Kim A NeveHeather Trantham-Davidson
Jun 29, 2006·The Journal of Pharmacology and Experimental Therapeutics·Jonathan D UrbanRichard B Mailman
Jul 17, 2007·Trends in Pharmacological Sciences·Brian K Kobilka, Xavier Deupi
Jul 17, 2007·Trends in Pharmacological Sciences·Richard B Mailman
Oct 24, 2007·Nature·Søren G F RasmussenBrian K Kobilka
May 16, 2008·Nature·Midori Murakami, Tsutomu Kouyama
Jun 20, 2008·Nature·Jung Hee ParkOliver P Ernst
Jul 3, 2008·Nature·Tony WarneGebhard F X Schertler
Jul 22, 2008·Journal of Molecular Biology·Supriyo BhattacharyaNagarajan Vaidehi
Sep 27, 2008·Nature·Patrick ScheererOliver P Ernst
Oct 30, 2008·Current Opinion in Structural Biology·William I Weis, Brian K Kobilka
Nov 6, 2008·Biochemical and Biophysical Research Communications·Kristoffer SahlholmPeter Arhem
Jul 25, 2009·Journal of Medicinal Chemistry·Juan Carlos MobarecMarta Filizola
Aug 4, 2009·Nature Chemical Biology·Yang HanJonathan A Javitch
Mar 2, 2010·Journal of Chemical Information and Modeling·Fiona M McRobbElizabeth Yuriev

Citations

Dec 4, 2013·Bioorganic & Medicinal Chemistry·Rune RisgaardAsk Püschl
Mar 27, 2018·Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents·Agnieszka A KaczorDariusz Matosiuk

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.